Early Access — free while we kick the tires
EdgarHawk

Derakhshan Behrad

Chief Business Officer

Officer
1 filing analyzed · 1 company · Latest 2024-09-24

Companies

Company Buys Sells Direction
Edgewise Therapeutics, Inc. EWTX 0 2 Net selling

Activity

September 2024
high
Sell
42,068 shares
$1,221,133
Significance 7/10

CBO Behrad sold 42,068 shares of EWTX at $29.03 for $1,221,133.08 (-73.6% of holdings)

Derakhshan Behrad, Chief Business Officer, executed a substantial divestiture selling 42,068 shares at $29.03 on 2024-09-20, reducing his holdings from 57,189 to 15,121 shares—a 73.6% reduction in position. The sale occurred near the company's 52-week high of $29.50, and the stock has subsequently declined 12.1% to a current price of $25.92. The timing is notable against the company's operating fundamentals: Edgewise reported a net loss of $31,497,000 over its most recent full fiscal year, making it an unprofitable company at the time of this transaction. The magnitude of the reduction—removing nearly three-quarters of his holdings in a single trade—represents a material change in insider ownership exposure.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access